CHORDOMA
Clinical trials for CHORDOMA explained in plain language.
Never miss a new study
Get alerted when new CHORDOMA trials appear
Sign up with your email to follow new studies for CHORDOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone cancer patients in drug trial
Disease control OngoingThis study is testing whether the drug cetuximab can help control advanced or spreading chordoma, a rare type of bone cancer. It involves adults whose cancer cannot be removed by surgery or has spread. The main goal is to see if the drug shrinks tumors and how long patients live …
Matched conditions: CHORDOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: CHORDOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Targeted proton therapy tested for rare skull tumor
Disease control OngoingThis study is testing whether proton beam radiation therapy can effectively control chordoma tumors at the base of the skull. Researchers want to find the right dose that treats the tumor while minimizing side effects. The treatment involves daily radiation sessions for about 7 w…
Matched conditions: CHORDOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo attack on rare bone cancer tests safety
Disease control OngoingThis early-phase study is checking the safety of combining an immunotherapy drug (nivolumab) with a very precise, high-dose radiation treatment for patients whose chordoma has come back or spread. It will enroll about 21 people to see how well they tolerate the treatments and to …
Matched conditions: CHORDOMA
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC